Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

Table 1

Topological analysis results.

Gene names	Betweenness	Closeness	Degree	Eigenvector	LAC	Network
TNF	38.06	0.95	33.00	0.23	20.12	31.65
IL6	35.21	0.95	33.00	0.23	20.55	31.97
JUN	23.88	0.88	30.00	0.22	19.80	27.35
MAPK8	32.28	0.88	30.00	0.21	17.93	25.81
AKT1	33.62	0.88	30.00	0.21	17.60	25.44
TP53	26.79	0.85	29.00	0.20	18.14	25.27
MAPK1	22.26	0.85	29.00	0.21	19.03	25.63
VEGFA	20.42	0.81	27.00	0.19	17.48	22.68
MMP9	17.80	0.80	26.00	0.19	17.31	21.55
IL1B	21.51	0.80	26.00	0.18	16.31	20.73
CXCL8	18.84	0.80	26.00	0.19	17.08	21.32
PTGS2	13.72	0.78	25.00	0.18	17.44	20.90
EGF	14.16	0.78	25.00	0.18	17.12	20.37
RELA	16.32	0.76	24.00	0.17	15.83	19.10
ICAM1	11.38	0.74	23.00	0.17	16.26	19.12
MAPK14	11.09	0.74	23.00	0.17	16.17	18.86